Phibro Animal Health (PAHC)
(Delayed Data from NSDQ)
$16.45 USD
-0.62 (-3.63%)
Updated May 6, 2024 04:00 PM ET
After-Market: $16.37 -0.08 (-0.49%) 7:58 PM ET
2-Buy of 5 2
A Value B Growth C Momentum A VGM
Industry / Sector Report
Industry : Medical - Products
Zacks Industry Rank
Bottom 40% (151 out of 252)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 4.25 | 1.69 | 9.99 |
Current Quarter Estimate | 0.29 | 5.88 | 57.00 |
Year Ago Quarter Estimate | 0.29 | 4.88 | 52.54 |
Next Quarter Estimate | 0.37 | 7.06 | 61.00 |
Next Year Estimate | 1.21 | 39.92 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | -7.44 | 18.40 | 15.67 |
Next Year | 8.04 | 24.30 | 9.31 |
Last 5 Years | -5.40 | 4.00 | 8.10 |
Next 5 Years | 2.40 | 10.80 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 14.97 | -13.85 |
Price/Book (MRQ) | 2.55 | 1.90 |
Price/Cash Flow (MRFY) | 8.26 | 10.67 |
Dividend Yield | 2.81% | 0.00% |
Net Profit Margin (TTM) | 1.51% | 12.53% |
Return on Equity (TTM) | 16.67% | 13.71% |
Debt to Equity (MRQ) | NA | 19.86 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.